151 related articles for article (PubMed ID: 7301901)
1. [On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)].
Hesse G; Schulze W; Wachtel E
Pharmazie; 1981 Sep; 36(9):609-12. PubMed ID: 7301901
[TBL] [Abstract][Full Text] [Related]
2. [Methodology of the colorimetric determination of alkylating cytostatics with 4-(4'-nitrobenzyl)pyridine (NBP) in plasma].
Sohr R; Schmeck G; Preiss R; Matthias M
Pharmazie; 1982 Nov; 37(11):777-9. PubMed ID: 7163361
[TBL] [Abstract][Full Text] [Related]
3. Different inhibitory effect of nitrogen mustard (HN2) and TS-160 (HN3) on choline transport in L 5178Y lymphoblasts.
Ujházy V; Kolarov J; Kuzela S; Krempaský V; Bohunická E
Neoplasma; 1975; 22(6):621-3. PubMed ID: 1240604
[TBL] [Abstract][Full Text] [Related]
4. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Niculescu-Duvăz I; Feyns V; Dobre V
Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the action of ionizing radiations and biological alkylating agents (nitrogen mustards) at the cellular and sub-cellular level.
ALEXANDER P
Sci Rep Ist Super Sanita; 1961 Oct; 1():537-50. PubMed ID: 13860356
[No Abstract] [Full Text] [Related]
7. Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration.
Williamson CE; Kirby JG; Miller JI; Sass S; Kramer SP; Seligman AM; Witten B
Cancer Res; 1966 Feb; 26(2):323-30. PubMed ID: 5903181
[No Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
[TBL] [Abstract][Full Text] [Related]
9. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.
Gourdie TA; Valu KK; Gravatt GL; Boritzki TJ; Baguley BC; Wakelin LP; Wilson WR; Woodgate PD; Denny WA
J Med Chem; 1990 Apr; 33(4):1177-86. PubMed ID: 2319563
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
11. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
12. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
[TBL] [Abstract][Full Text] [Related]
14. Anticancer potentiality of three new synthetic nitrogen mustards.
Téllez-Martínez J; García-Cavazos R; Yáñez R; González-Diddi M
Arch Invest Med (Mex); 1983; 14(2):159-71. PubMed ID: 6639257
[No Abstract] [Full Text] [Related]
15. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
[TBL] [Abstract][Full Text] [Related]
16. [Determination of alkylating agents in biological fluids. Method using the color reaction with 4-(4-nitrobenzyl)-pyridine in an alkaline medium].
TRUHAUT R; DELACOUX E; BOHUON B; BOHUON C
Clin Chim Acta; 1963 Mar; 8():235-45. PubMed ID: 13994366
[No Abstract] [Full Text] [Related]
17. [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].
DANNEBERG P; DRUCKREY H; KAISER K; LO HW; MECKE R; NIEPER HA; SCHMAHL D
Arzneimittelforschung; 1956 Sep; 6(9):539-50. PubMed ID: 13373668
[No Abstract] [Full Text] [Related]
18. Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area.
Bădilescu II; Crăescu T; Niculescu-Duvăz I; Simon Z
Neoplasma; 1980; 27(3):261-9. PubMed ID: 7453846
[TBL] [Abstract][Full Text] [Related]
19. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR/CoMFA and CoMSIA studies on antileukemic steroidal esters coupled with conformationally flexible nitrogen mustards.
Kapou A; Benetis NP; Durdagi S; Nikolaropoulos S; Mavromoustakos T
J Chem Inf Model; 2008 Nov; 48(11):2254-64. PubMed ID: 18954137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
